Pittsburgh, PA5 Active Studies

Parkinsons Disease Clinical Trials in Pittsburgh, PA

Find 5 actively recruiting parkinsons disease clinical trials in Pittsburgh, PA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
5,328
Enrolling

Recruiting Parkinsons Disease Studies in Pittsburgh

About Parkinsons Disease Clinical Trials in Pittsburgh

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 5 parkinsons disease clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 5,328 participants. Research is being sponsored by Boston Scientific Corporation, Nuvaira, Inc., Jorge Gonzalez-Martinez and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Pittsburgh — FAQ

Are there parkinsons disease clinical trials in Pittsburgh?

Yes, there are 5 parkinsons disease clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 5 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 17, 2026 from ClinicalTrials.gov